Indies Pharma is reporting a net profit increase of $48.6 million or 107 per cent for the quarter when compared to the corresponding period in the previous year.
The recently listed company also generated more than $168.1 million in revenue for its first quarter ending January 31, 2019.
This amount reflects an 11.23 per cent increase over the corresponding quarter in 2018.
Significant increases were incurred for security expenses which went up by 106 per cent.
comments powered by Disqus
.jpg)
All feeds
